Featured article:
Constitutional Mosaic Epimutations – a hidden cause of cancer?
Per E. Lønning, Hans P. Eikesdal, Inger M. Løes and Stian Knappskog
Silencing of tumor suppressor genes by promoter hypermethylation is a key mechanism to facilitate cancer progression in many malignancies. While promoter hypermethylation can occur at later stages of the carcinogenesis process, constitutional methylation of key tumor suppressors may be an initiating event whereby cancer is started. Constitutional BRCA1 methylation due to cis-acting germline genetic variants is associated with a high risk of breast and ovarian cancer. However, this seems to be a rare event, restricted to a very limited number of families. In contrast, mosaic constitutional BRCA1 methylation is detected in 4-7% of newborn females without germline BRCA1 mutations. While the cause of such methylation is poorly understood, mosaic normal tissue BRCA1 methylation is associated with a 2-3 fold increased risk of high-grade serous ovarian cancer (HGSOC). As such, BRCA1 methylation may be the cause of a significant number of ovarian cancers. Given the molecular similarities between HGSOC and basal-like breast cancer, the (…)
About us
Meet the editorial board
Publish with us
Connect with us
Indexed in DOAJ
News
Most viewed articles
- Nucleolar Stress: hallmarks, sensing mechanism and diseases
- Mitochondrial stress management: a dynamic journey
- The emerging role of minor intron splicing in neurological disorders
- VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress
- R-loops: formation, function, and relevance to cell stress